We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGL Angle Plc

0.25 (2.13%)
Dec 06 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Angle Plc AGL London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.25 2.13% 12.00 06:14:17
Open Price Low Price High Price Close Price Previous Close
11.75 11.25 12.00 12.00 11.75
more quote information »
Industry Sector

Recent News

Date Time Source Heading
12/05/202305:50ALNCNewsIN BRIEF: Angle launches diagnostic kit at cancer symposium
12/05/202301:00RNSNONAngle PLC ANGLE launches Portrait+ CTC kit at SABCS
11/09/202308:29ALNCNewsAngle says build up of revenue slower than hoped; launches..
11/09/202301:00RNSNONAngle PLC Launch of PD-L1 test to support cancer studies
10/25/202311:28ALNCNewsTRADING UPDATES: Franchise Brands trading in line; Tribe..
10/25/202301:00RNSNONAngle PLC Supporting characterisation of CTCs in HNSCC
10/03/202307:02ALNCNewsAngle hails study which shows Parsortix outperforming lab..
10/03/202301:00RNSNONAngle PLC Parsortix outperforms standard for DTC harvest
9/29/202301:00RNSNONAngle PLC Parsortix system showcased at ACTC conference
9/07/202308:41ALNCNewsEARNINGS UPDATES: Sylvania beats production goal, Angle..
9/07/202301:00UKREGAngle PLC Interim Results for the period ended 30 June 2023
9/04/202308:21ALNCNewsAngle launches tumour cell assay to "unlock" customised..
9/04/202301:00RNSNONAngle PLC ANGLE launch of Portrait Flex assay
8/15/202301:00UKREGAngle PLC ANGLE notice of interim results
6/28/202310:54UKREGAngle PLC Result of 2023 Annual General Meeting
6/27/202306:24UKREGAngle PLC Standard form for notification of major holdings
6/05/202306:26ALNCNewsIN BRIEF: Angle hires Swansiger as new COO and Miller as new..
6/05/202301:00RNSNONAngle PLC ANGLE announces senior management appointments
5/25/202308:34ALNCNewsIN BRIEF: Angle customer to use biopsy products in clinical..
5/25/202301:00UKREGAngle PLC Pharma services contract with Artios Pharma
5/22/202307:53ALNCNewsIN BRIEF: Angle promotes Jan Groen to chair, replacing Garth..
5/22/202301:00UKREGAngle PLC Board change - appointment of new Chairman
4/21/202306:04RNSNONAngle PLC ANGLE presentation via Investor Meet Company
4/21/202304:43ALNCNewsAngle loss widens in 2022 despite being "breakthrough" year
4/21/202301:00UKREGAngle PLC Results for the year ended 31 December 2022
4/19/202311:37ALNCNewsTRADING UPDATES: Angle partners with BioView; First Class..
4/19/202301:00UKREGAngle PLC ANGLE announces partnership with BioView
4/17/202301:00RNSNONAngle PLC ANGLE Parsortix poster presented at AACR 2023
4/13/202304:52ALNCNewsTRADING UPDATES: Datalex and SpaceandPeople extend deals
4/13/202301:00UKREGAngle PLC Pharma Services Contract with Crescendo Biologics
4/03/202301:00UKREGAngle PLC Notice of Preliminary Results and Webcast
3/10/202301:00UKREGAngle PLC Issue of LTIP Options and Share Options
3/09/202309:03UKREGAngle PLC Holding(s) in Company
2/09/202308:44UKREGAngle PLC Director/PDMR shareholding
1/19/202301:00UKREGAngle PLC Appointment of Non-Executive Director
1/11/202311:20UKREGAngle PLC Holding(s) in Company
1/10/202312:20UKREGAngle PLC Holding(s) in Company
1/06/202305:05UKREGAngle PLC Second Price Monitoring Extn
1/06/202305:00UKREGAngle PLC Price Monitoring Extension
1/05/202306:45ALNCNewsTAKING AIM: Berenberg says Angle needs "patience" as outlook..
1/05/202304:25ALNCNewsAngle expects 2023 growth to fall short of market..
1/05/202303:05UKREGAngle PLC Second Price Monitoring Extn
1/05/202303:00UKREGAngle PLC Price Monitoring Extension
1/05/202301:01UKREGAngle PLC Appointment of Non-Executive Director
1/05/202301:00UKREGAngle PLC Business Update
12/12/202201:00RNSNONAngle PLC Two Parsortix posters presented at SABCS

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |